CelldexCLDX
NASDAQDiagnostics
No cached AI snapshot yet for CLDX.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
198 employees78.46M shares outstandinglisted 1986-05-15
Next earnings ~May 5, 2026
About Celldex
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Latest News
Showing market-wide stock news
Treasury ETF shorts shift toward belly ahead of Fed decision
BoE to 'stand ready to hike', committee remains 'deeply divided'
The Fed’s interest rate decision in the epicenter of attention
News Flash: 70% of Wall Street Institutions Are Calling for at Least a 50-Basis-Point Fed Rate Hike in 2026
Nifty holds above 23,250 level; European shares trade mostly in green
The Stock Market Is Sending a Rare Historical Warning. Warren Buffett Says Investors Should Make This 1 Move.
Related Stocksin Diagnostics
Ready to see the live AI view on CLDX?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing CLDX side-by-side with live signals.